A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 165 participants.

Also called NCT02434263

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 165 participants (planned count) (from the registry)
Sponsor
Vascular Innovations Co. Ltd. (from the registry)
Registry
  • NCT NCT02434263
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Greece, Hong Kong SAR China, Lithuania, New Zealand, Poland, Thailand (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02434263. Allocation not applicable; no masking; primary purpose treatment. Start 2015-08-13 (actual); primary completion 2022-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve
Condition
Aortic Valve Stenosis
Intervention (Device)
Hydra TAVI
Lead sponsor
Vascular Innovations Co. Ltd. (class: industry)
Collaborator
MedPass International (class: industry)

Record details

Record id
cardio:ct-nct02434263
Content hash
fa049d533e8d2684ffad0e580b8e2362c290a6cef574a6c03f2d7ad4ab4a68db